Innovative service models to support deprescribing in hospital
Sedative and anticholinergic drugs are commonly associated with harm in older adults. The Drug Burden Index (DBI) developed by Professor Sarah Hilmer, is a validated clinical risk assessment tool which measures exposure to anticholinergics and sedatives. A bundle of resources, including the DBI in the electronic Medical Records (eMR) have been implemented in Northern Sydney Local Health District (NSLHD) and Central Coast Local Health District (CCLHD) hospitals in NSW, to help clinicians identify and prioritise high-risk older patients for medication review and facilitate deprescribing of DBI-contributing drugs where appropriate.
Click here to read more!
Researchers across Australia and internationally are working on projects to inform deprescribing in practice.
Click through to find out about our upcoming events.
Click here for detail on how to contact us, including media contacts. You can also subscribe to our newsletter.
Thompson, Wade, et al. “GP preferences for discussing statin deprescribing: a discrete choice experiment.” Family Practice (2021).
Leveraging implementation science to increase the translation of deprescribing evidence into practice
Citation: Ailabouni, Nagham J., et al. “Leveraging implementation science to increase the translation of deprescribing evidence into practice.” Research in Social and Administrative Pharmacy (2021).
Appropriate deprescribing in older people: a challenging necessity Commentary to accompany themed collection on deprescribing
Citation: van der Velde, Nathalie, and Jatinder S. Minhas. “Appropriate deprescribing in older people: a challenging necessity Commentary to accompany themed collection on deprescribing.” Age and Ageing (2021).